References
-
1
Agelink M W, Malessa R, Kamcili E, Zeit T, Lemmer W, Bertling R, Klieser E.
Cardiovascular autonomic reactivity in schizophrenics under neuroleptic treatment: A potential predictor of short term outcome?.
Neuropsychobiology.
1998;
38
19-24
-
2
Breier A.
Clozapine and noradrenergic function: Support for a novel hypothesis for superior efficacy.
J Clin Psychiatry.
1994;
55 (suppl B)
122-125
-
3
Eschweiler G W, Bartels M, Längle G, Wild B, Gaertner I, Nickola M.
Heart rate variability in the ECG trace of routine EEGs: Fast monitoring for the anticholinergic effects of clozapine and olanzapine?.
Pharmacopsychiatry.
2002;
35
96-100
-
4
Kingwell B A, Thompson J M, Kaye D M, McPherson G A, Jennings G L, Esler M D.
Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure.
Circulation.
1994;
90
234-240
-
5
Toichi M, Kubota Y, Murai T, Kamio Y, Sakihama M, Toriuchi T, Inakuma T, Sengoku A, Miyoshi K.
The influence of psychotic states on the autonomic nervous system in schizophrenia.
Int J Psychophysiol.
1999;
31
147-154
Marcus W. Agelink, MD
Dept. of Psychiatry, Psychotherapy & Psychosomatic Medicine
Evangl. Clinics Gelsenkirchen
Ruhr-University of Bochum
Munckelstr. 27
D-45879 Gelsenkirchen
Telefon: 0049-209/160-1601
Fax: 0049-209/160-2685
